FDA details approach for finding optimal dosages for new cancer drugs

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy